PAC1 phosphatase is a transcription target of p53 in signalling apoptosis and growth suppression

p53 has a role in many cellular processes through the transcriptional regulation of target genes. PAC1 (phosphatase of activated cells 1; also known as dual specificity phosphatase 2, DUSP2) is a dual threonine/tyrosine phosphatase that specifically dephosphorylates and inactivates mitogen-activated protein (MAP) kinases. Here we show that during apoptosis, p53 activates transcription of PAC1 by binding to a palindromic site in the PAC1 promoter. PAC1 transcription is induced in response to serum deprivation and oxidative stress, which results in p53-dependent apoptosis, but not in response to γ-irradiation, which causes cell cycle arrest. Reduction of PAC1 transcription using small interfering RNA inhibits p53-mediated apoptosis, whereas overexpression of PAC1 increases susceptibility to apoptosis and suppresses tumour formation. Moreover, activation of p53 significantly inhibits MAP kinase activity. We conclude that, under specific stress conditions, p53 regulates transcription of PAC1 through a new p53-binding site, and that PAC1 is necessary and sufficient for p53-mediated apoptosis. Identification of a palindromic motif as a p53-binding site may reveal a novel mechanism whereby p53 regulates its target genes.

[1]  B. Vogelstein,et al.  Suppression of human colorectal carcinoma cell growth by wild-type p53. , 1990, Science.

[2]  M. Karin,et al.  c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases , 1994, Molecular and cellular biology.

[3]  A. Fire,et al.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.

[4]  K. Kinzler,et al.  Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. , 1995, Cancer research.

[5]  Wei Gu,et al.  Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain , 1997, Cell.

[6]  V. Rotter,et al.  A DNA binding domain is contained in the C-terminus of wild type p53 protein. , 1991, Nucleic acids research.

[7]  K. Kinzler,et al.  Definition of a consensus binding site for p53 , 1992, Nature Genetics.

[8]  James Brugarolas,et al.  Radiation-induced cell cycle arrest compromised by p21 deficiency , 1995, Nature.

[9]  P. Shaw,et al.  Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. C. Maiyar,et al.  p53 Stimulates Promoter Activity of the sgk Serum/Glucocorticoid-inducible Serine/Threonine Protein Kinase Gene in Rodent Mammary Epithelial Cells (*) , 1996, The Journal of Biological Chemistry.

[11]  B. Kennedy,et al.  NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. , 2000, Genes & development.

[12]  J. Levine,et al.  Surfing the p53 network , 2000, Nature.

[13]  D. Notterman,et al.  Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. , 2000, Genes & development.

[14]  P. Rangarajan,et al.  Involvement of p85 in p53-dependent apoptotic response to oxidative stress , 1998, Nature.

[15]  Deri Morgan,et al.  The voltage dependence of NADPH oxidase reveals why phagocytes need proton channels , 2003, Nature.

[16]  E. Nishida,et al.  The MAP kinase cascade is essential for diverse signal transduction pathways. , 1993, Trends in biochemical sciences.

[17]  G. Wahl,et al.  Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Kathleen Kelly,et al.  Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1 , 1994, Nature.

[19]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[20]  J. Barrett,et al.  Differential regulation of p21 by p53 and Rb in cellular response to oxidative stress , 1999, Molecular carcinogenesis.

[21]  B. Vogelstein,et al.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.

[22]  C. Moskaluk,et al.  PAC-1: a mitogen-induced nuclear protein tyrosine phosphatase. , 1993, Science.

[23]  W. Forrester,et al.  A DNA vector-based RNAi technology to suppress gene expression in mammalian cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Levine p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.